The transcription factor Bach2, a member of the BTBbasic region leucine zipper (bZip) factor family, binds to a 12-O-tetradecanoylphorbol-13-acetate (TPA)-responsive element and the related Maf-recognition element (MARE) by forming homodimers or heterodimers with Maf-related transcription factors. Bach2 regulates transcription by binding to these elements. To understand the function in hematopoiesis, we isolated a cDNA clone for human Bach2 (BACH2) encoding a protein of 841 amino acid residues with a deduced amino acid sequence having 89.5% identity to mouse homolog. Among human hematopoietic cell lines, BACH2 is expressed abundantly only in some B-lymphocytic cell lines. RT ± PCR analysis of hematopoietic cells revealed that BACH2 mRNA is expressed in primary B-cells. Enforced expression of BACH2 in a human Burkitt cell line, RAJI that does not express endogenous BACH2, resulted in marked reduction of clonogenic activity, indicating that BACH2 possesses an inhibitory eect on cell proliferation. Bȳ uorescent in situ hybridization, the BACH2 gene was localized to chromosome 6q15. Because deletion of the long arm of chromosome 6 (6q) is one of the commonest chromosomal alterations in human B-cell lymphoma, we examined for the loss of heterozygosity (LOH) of the BACH2 gene in human B-cell non-Hodgkin's lymphomas (NHL). Among 25 informative cases, ®ve (20%) showed LOH. These results indicate that BACH2 plays important roles in regulation of B cell development.
The transcription factor Bach2, a member of the BTBbasic region leucine zipper (bZip) factor family, binds to a 12-O-tetradecanoylphorbol-13-acetate (TPA)-responsive element and the related Maf-recognition element (MARE) by forming homodimers or heterodimers with Maf-related transcription factors. Bach2 regulates transcription by binding to these elements. To understand the function in hematopoiesis, we isolated a cDNA clone for human Bach2 (BACH2) encoding a protein of 841 amino acid residues with a deduced amino acid sequence having 89.5% identity to mouse homolog. Among human hematopoietic cell lines, BACH2 is expressed abundantly only in some B-lymphocytic cell lines. RT ± PCR analysis of hematopoietic cells revealed that BACH2 mRNA is expressed in primary B-cells. Enforced expression of BACH2 in a human Burkitt cell line, RAJI that does not express endogenous BACH2, resulted in marked reduction of clonogenic activity, indicating that BACH2 possesses an inhibitory eect on cell proliferation. Bȳ uorescent in situ hybridization, the BACH2 gene was localized to chromosome 6q15. Because deletion of the long arm of chromosome 6 (6q) is one of the commonest chromosomal alterations in human B-cell lymphoma, we examined for the loss of heterozygosity (LOH) of the BACH2 gene in human B-cell non-Hodgkin's lymphomas
Introduction
The Maf family transcription factors possess a conserved basic region-leucine zipper (bZip) domain which mediates protein/protein interaction and DNA binding (Nishizawa et al., 1989; Kataoka et al., 1993) . While c-Maf, MafB and NRL contain putative transcription activation domains (Kataoko et al., 1994a; Nishizawa et al., 1989; Swaroop et al., 1992) , MafF, MafK and MafG lack canonical transactivation domains (Andrews et al., 1993b; Blank et al., 1997; Fujiwara et al., 1993; Igarashi et al., 1995; Kataoka et al., 1995; Toki et al., 1997) . MafF, MafG and MafK are essentially composed of bZip domains and are collectively referred to as the small Maf family proteins. Various dimeric combinations of Maf family proteins bind in vitro to a DNA sequence motif called T-MARE (TGCTGA G / C TCAGCA) that contains a TPA-responsive element (TRE; TGA G / C T-CA) (Kataoka et al., 1994a (Kataoka et al., ,b, 1995 . The small Maf proteins form heterodimers with a family of bZip proteins that show remarkable homology to two invertebrate proteins, CNC and skn-1, which regulate embryonic development in Drosophila melanogaster and Caenorhabditis elegans, respectively (Mohler et al., 1991 (Mohler et al., , 1995 Bowerman et al., 1992) . This family of factors, referred to as the CNC family, include p45 NF-E2, Nrf1/LCR-F1/TCF-11, Nrf2, and Nrf3, all of which are similar in the bZip domain and form heterodimers with small Maf proteins (Andrews et al., 1993a,b; Chan et al., 1993a,b; Ney et al., 1993; Caterina et al., 1994; Moi et al., 1994; Igarashi et al., 1994 Igarashi et al., , 1995 Marini et al., 1997; Johnsen et al., 1996; Toki et al., 1997; Kobayashi et al., 1999) . Gene targeting has revealed distinct roles for several CNC family members in mammalian gene regulation. Homozygous disruption of p45 NF-E2 gene in mouse results in defective megakaryopoiesis and profound thrombocytopenia, leading to postnatal death (Shivdasani et al., 1995) . Nrf-1-null mutant mice are anemic due to a noncell autonomous defect in de®nitive erythropoiesis and die in utero (Chan et al., 1998) . Nrf-2-null mutant mice are viable but impaired in the xenobiotic inductive response of phase II detoxifying enzyme gene .
The murine Bach proteins (Bach1 and Bach2) were ®rst isolated as molecules that interact with MafK by yeast two hybrid screenings and were found to possess A Cloning and expression of BACH2 transcription factor S Sasaki et al a CNC-related and less conserved bZip domain (Oyake et al., 1996) . In addition to the bZip domain, Bach proteins share a signature motif called the Bric-a-brac, Tramtrack and Broad complex (BTB) domain which is involved in protein ± protein interactions (Albagli et al., 1995) . Heterodimers of small Maf proteins and the CNC-related factors bind to the NF-E2 consensus site (TGCTGA G / C TCA T / C ) which is related to MARE (Caterina et al., 1994; Chan et al., 1993a,b; Johnsen et al., 1996; Marini et al., 1997; Moi et al., 1994; Oyake et al., 1996; Toki et al., 1997) . Among these CNC family proteins, the Bach proteins take a unique position in that they function as transcription repressors rather than activators in transient transfection assays (Oyake et al., 1996) . However, the precise role of these potential heterodimers during development and cell dierentiation has remained elusive.
To understand the function of Bach factors in human cells, we isolated a cDNA clone for human Bach2 (BACH2) and determined the chromosomal position for BACH2 and its expression in various tissues and hematopoietic cell lines. Among various hematopoietic cell lines, BACH2 was expressed abundantly only in some B-lymphocytic cell lines. Enforced expression of BACH2 in a human Burkitt cell line, RAJI that does not express endogenous BACH2, resulted in a marked reduction of clonogenic eciency. The BACH2 gene is mapped to chromosome 6q15, in a region where minimal molecular deletion (RMD) is frequently detected in B-cell NHLs, and we have found LOH of BACH2 in ®ve out of 25 B-NHL cases (20%). These results have led to speculation that BACH2 may play an important role in B cell development. 
Results

Molecular cloning of BACH2 cDNA
A screening of 1610 6 independent clones of a human endothelial cell cDNA library under relaxed hybridization conditions using a mouse bach2 cDNA as a probe resulted in isolation of seven positive clones. Upon Southern hybridization and sequence analysis, clone #61 was found to encode BACH2 based on a similarity to its mouse homolog. Since clone #61 was found to be a partial cDNA, we screened another cDNA library from human erythroleukemia cell line K562 using the mouse Bach2 cDNA probe and isolated a full-length clone ( Figure  1a) . A comparison of the deduced amino acid sequences of mouse and human Bach2/BACH2 is shown in Figure 1b . A high degree of conservation along the entire ORF is evident. As is the case for mouse Bach2, the BACH2 sequence contained a BTB domain (from aa 1 ± 120) and a bZip domain (from aa 491 ± 585). Out of the 120 amino acid residues in the BTB domain, 117 residues (97.5%) were found to be identical between the two species. The bZip regions showed a 96.8% identity. In addition to these known functional domains, we found another well-conserved region, adjacent to the bZip domain, including the so-called serine-rich region (Oyake et al., 1996) : 184 residues (94%) out of a total of 195 were found to be identical. Such a high degree of conservation suggests functional importance for these domains.
BACH2 is abundantly expressed in some B cell lines
To determine expression of BACH2 in various tissues, we analysed a panel of human tissues by Northern hybridization analysis. As shown in Figure  2a , the human BACH2 mRNA (approximately 11 kb in length) was essentially restricted to the thymus, spleen, and leukocytes. Relatively low levels of BACH2 expression were also detected in the small intestine and brain. Because the expression sites of BACH2 were hematopoietic tissues, we next examined BACH2 expression in various hematopoietic cell lines representing dierent cell lineages (Figure 2b ). The BACH2 mRNA was found in T lymphoid (CEM) and erythro-megakaryocytic (K562) cells, whereas it was barely detectable in B-lymphoid (RAJI), myeloid-monocytoid (KG-1, HL60, THP1 and U937), and other erythro-megakaryocytic (CMK86, CMK11-5, MGS, MEG01, KU812F, HEL and YN-1) cell lines. Because BACH2 expression was most abundant in a T lymphoid cell line, we next examined various lymphoid cell lines ( Figure 2c ). Unexpectedly, very high levels of expression of the BACH2 mRNA were detected in some B-lymphoid (NALL1, NALM6, NALM17, NAMALWA) cell lines, although it was lacking in three others (BALM2, RAJI and RPMI18226). The levels of expression of BACH2 in T lymphoid (CEM, KOPT-K1, THP-6, KOPY-K1) cell lines were found to be relatively low compared with some of the B-lymphoid cell lines. To con®rm these results, immunoblotting analysis with anti-BACH2 antiserum was performed (Figure 2d ). BACH2 was found to be expressed in all B-precursor cell lines (NALL1, NALM6, and NALM17), three out of ®ve Burkitt cell lines (NAMALWA, RAMOS, and Daudi) and two out of ®ve multiple myeloma cell lines . However, BACH2 expression was lacking in two Burkitt cell lines (BALM2, RAJI) and three myeloma (or plasmacytoma) cell lines (RPMI 1788, IM9, RPMI8226). The expression pro®le of the BACH2 protein in dierent B cell lines correlated well with the presence of BACH2 mRNA.
BACH2 is expressed in primary B cells
To examine whether BACH2 is expressed in primary B-cells in a stage-speci®c manner, we ®rst separated human cord blood cells into two fractions by cell sorting using antibodies against CD34 and CD10. The two fractions were (1) CD34+, CD10-(hematopoietic progenitor cells), and (2) CD34+, CD10+ (progenitor B cells at early stage). To obtain more mature progenitor B-cells or precursor B-cells, we used a long-term culture system using the murine bone marrow stromal cells MS-5 (Nishihara et al., 1998) . Fractionated CD34 + hematopoietic progenitor cells from human cord blood were cultured on MS-5 in the presence of rhSCF and rhG-CSF for 5 weeks. Flow cytometric analysis was performed on adherent cells with the gate for the lymphocyte fraction. About 95% of the cells showed phenotypes of CD10+/19+. These cells did not express CD34 or IgM on the cell surface. A small part of the cells expressed cytoplasmic m chain, suggesting that these cells are progenitor B cells or precursor B cells. BACH2 expression in each fraction was analysed by RT ± PCR. Only the CD10+/19+ fraction showed BACH2 mRNA expression, whereas the CD34+/ CD107 and CD34+/CD10+ fraction did not express BACH2 (Figure 3a) .
To analyse BACH2 expression in the later stage of B-cell development, we next separated immature B-cells and mature B-cells from adult peripheral blood cells by cell sorting using the B-cell speci®c antibodies. The CD19+/CD21+/IgD7 fraction and the CD19+/ CD21+/IgD+ fraction represent immature B-cells and mature B-cells, respectively. As shown in Figure  3b , BACH2 was expressed in both immature B-cells and mature B-cells, and the expression level was comparable to that of some B-cell lines. These results established that BACH2 is expressed in primary B-cells at the progenitor B, precursor B, immature B and mature B stages.
Forced expression of BACH2 resulted in reduced colony formation potential in a human B-lymphoma cell line, RAJI cells Mouse Bach2 forms heterodimers with the Maf oncoprotein family (Oyake et al., 1996) . Thus, BACH2 may be involved in regulation of cell proliferation. To test this possibility, we examined the eects of BACH2 over-expression in the Burkitt lymphoma cell line RAJI, which does not express endogenous BACH2. RAJI cells were infected with the retrovirus harboring the human BACH2 cDNA, and stably transduced RAJI clones were selected in the presence of G418. As control lines, stable RAJI clones, which were transduced with the same vector lacking the BACH2 cDNA, were also established. Expression levels of BACH2 protein were veri®ed by a blot analysis using antiBach2 polyclonal antibodies. Six BACH2 RAJI clones abundantly expressed BACH2 protein, whereas the control clone lacked its expression (Figure 4a ). Two clones that over-expressed BACH2 at the highest level were studied further. Generations of MARE-binding activities within these cells were then examined in electrophoretic mobility shift (EMSA) assay. As shown in Figure 4b , a prominent MARE-binding activity was detected in the BACH2 over-expression lines but not in the control lines (compare lanes 2 ± 5). The speci®city was con®rmed by the inhibition of the complex formation in the presence of excess unlabeled MARE oligonucleotide (data not shown). The complex contained both BACH2 and small Maf protein, since anti-BACH2 monoclonal antibodies super-shifted the complex (lanes 6 and 7) and anti-small Maf antiserum inhibited the MARE binding activity (lanes 8 and 9). These results indicated that over-expressed BACH2 generated the MARE binding complex together with one or other of the small Maf proteins within RAJI cells.
Having established RAJI cell lines that overexpressed BACH2, we examined its eect on cell growth in two kinds of assays. One was to monitor growth curves, and the other was to monitor colony formation activity. The latter assay is more stringent in terms of cell proliferation. The BACH2 over-expressing lines showed roughly similar curves to those of the control lines when monitored in liquid cultures (data not shown). On the other hand, the forced expression of BACH2 caused signi®cant eects on the growth properties in RAJI cells in methylcellulose colony assay. The plating eciency of control clones was about 40 ± 60%. In contrast, the plating eciencies of all RAJI clones which expressed BACH2 was found to be consistently and signi®cantly reduced (10 ± 40%) ( Figure 5b) . Furthermore, the average size of the colonies from BACH2 expressing RAJI clones was smaller than those from control clones (Figure 5a ). These results suggested that BACH2 is a negative regulator of clonogenic activity.
Isolation of a genomic clone and chromosome location of BACH2 gene
The human BACH2 was shown to be a unique gene by Southern hybridization analysis (data not shown). Human BACH2 cDNA probes were then used to screen a commercial P1 human genomic library (Genomic Systems, St Louis, MO, USA) and a BACH2 genomic clone was isolated. Metaphase cells were examined by FISH using the P1 clone as a probe. Examination of these chromosomal spreads allowed us to localize the human BACH2 gene to 6q15 (Figure 6 ). Hybridization eciency for the BACH2 probe was approximately 95%. No consistent hybridization signal was observed at any other site.
LOH of BACH2 gene was found in B-NHL patients with a relatively high frequency
Deletions of chromosome 6 is commonly detected in human B-cell lymphoma by both cytogenetic and LOH analyses (Guan et al., 1996) . As BACH2 was expressed EMSA was carried out with oligonucleotide probe which contains MARE in the HS3/Ca3'E (Muto et al., 1998) , and extracts were prepared from the indicated cell lines. Antibodies were anti-Bach2 monoclonal antibody (Muto et al., 1998 ; lanes 6 and 7), antiMafK rabbit serum that reacts with the small Maf proteins (lanes 8 and 9), or preimmune serum (lanes 10 and 11). Bach2/small Maf complex is indicated with arrow Figure 5 Comparative analysis of plating eciency of BACH2 transfectants. Methylcellulose colony formation assay was performed as described in Materials and methods. As a control, stable RAJI clones, which were transduced with the pDL+ vector lacking the BACH2 cDNA, were used. (a) Colonies were photographed 2 weeks after plating. (b) The relative plating eciency was examined 11 days after plating at high levels in B-lymphocytic lineage, forced expression of BACH2 in a B-cell line resulted in reduced growth potential, and its gene was located at 6q15, we investigated whether it is altered in B-cell lymphomas. To examine LOH, a polymorphic (CA)n repeat microsatellite marker (BACH2/CA-1, see Materials and methods) was ®rst isolated from the human BACH2 P1 phage genomic clone. LOH was then analysed in pairs of normal DNA (peripheral blood) and tumor DNA from 30 B-NHL cases using the BACH2/CA-1 microsatellite marker. The average size of the PCR product is about 170 bp, which depends on the number of CA repeats. The BACH2/CA-1 microsatellite marker was found to be heterozygous and informative for LOH analysis in 25 out of 30 cases. Representative LOH results obtained with this marker are shown in Figure 7 . LOH was found in ®ve patients out of the 25 informative patients (20%). Seven cases had LOH in another microsatellite marker D6S292, located on chromosome 6q16.3-q23.2. All ®ve patients with LOH of marker BACH2/CA-1 were also found to have the LOH at D6S292. These results indicate that LOH of BACH2 is associated with NHL with a relatively high frequency.
Discussion
In the present study, we have described for the ®rst time the isolation and characterization of human cDNAs encoding the BACH2 protein. The results of Northern hybridization and Western blot analyses indicated that BACH2 was expressed at a high level in human B cell lines. Over-expression of BACH2 resulted in reduced colony formation potential in the human B-lymphoma cell line, RAJI. Furthermore, FISH analysis showed the BACH2 gene to be localized to chromosome 6q15, where alterations have been often reported in human B-cell lymphomas (Guan et al., 1996) . Indeed, we detected LOH of the BACH2 gene in ®ve out of 25 patients with B-cell NHL. These data, coupled with the observation that BACH2 is expressed in primary B cells, have led to speculation that BACH2 may play an important regulatory role in B cell development.
In the mouse, Bach2 is expressed in pro-B, pre-B, immature B and mature B cell lines, and it is absent in plasmacytoma cell lines (Muto et al., 1998) . In human B-lymphoid cell lines, Northern hybridization and Western blot analyses revealed abundant expression in three pre-B cell lines, NALM-1, NALM-6 and NALM-17, and three immature B cell lines, NAMAL-WA, RAMOS and Daudi. In contrast, BACH2 expression was not detected in three multiple myeloma cell lines (or plasma cell lines), RPMI 8226, IM9 and RPMI 1788. These results support the notion that BACH2 is expressed in B cells in a stage-speci®c manner. However, two Burkitt lymphoma cell lines, RAJI and BALM2, which are in pre-B and immature-B cell stages, respectively, did not express BACH2. Considering the fact that BACH2 is expressed in primary human B cells at corresponding stages, these results suggest that BACH2 expression is deregulated in these tumor cell lines due to abnormalities in either trans-or cis-factors.
Two multiple myeloma cell lines abundantly expressed BACH2. Multiple myeloma is characterized by extensive in®ltration of the bone marrow by monoclonal plasma cells. However, the self-renewing stem cell in myeloma is likely to be a B-lineage cell that is less mature than the end-stage plasma cells in the bone marrow (Caligaris-Cappio et al., 1985) . High level of BACH2 expression indicates that these two cell lines established from multiple myeloma patients may not represent plasma cells. Alternatively, BACH2 may be deregulated in these myeloma cell lines. Because multiple myeloma is a heterogeneous disorder, BACH2 expression might be a useful marker for classi®cation of multiple myelomas.
Human tumors have been shown to progress by accumulation of genetic abnormalities, with frequent recurrent chromosomal changes which cause alterations in the expression of oncogenes or tumor suppressor genes (Fearon and Vogelstein, 1990) . Non-random loss of heterozygosity (LOH) of chromosomal regions has often been observed in various human tumors, and these areas are likely to harbor tumor suppressor genes whose mutations are respon- (6q) is one of the commonest chromosomal changes in all non-Hodgkin's lymphomas (NHL) (Ot et al., 1993 (Ot et al., , 1994 Gaidano et al., 1992) and acute lymphoblastic leukemias (ALL) (Hayashi et al., 1990) . Along 6q, several regions of convergent deletions have been reported: (1) two regions of minimal molecular deletion (RMDs) termed RMD1 (localized to 6q25 ± 27) and RMD2 (localized to 6q21 ± 23) determined by LOH studies (Ot et al., 1993) , (2) two common regions of deletions at 6q23.2 ± 27 and 6q14 ± 21 in ALL detected by¯uorescent in situ hybridization (FISH) of yeast arti®cial chromosome clones mapped by 6q (Menasce et al., 1994) , (3) RMD encompassing 6q11 ± 21 in B-cell lymphoma found by Micro-FISH techniques (Guan et al., 1996) , and (4) RMD of less than 500 kb in chromosome 6q16 ± 21 in ALL revealed by LOH studies (Merup et al., 1998) . These observations suggest that the 16q region may contain multiple tumor suppressor genes. However, candidate tumor suppressor genes in this chromosomal region have yet to be described. The present FISH results revealed that BACH2 is located in the middle of the RMD encompassing 6q11 ± 21 in B-cell lymphoma. The present LOH analysis revealed a relatively high frequency of LOH of BACH2 gene (20%) in human B-cell lymphomas. However, we cannot exclude the possibility that the BACH2 gene may be deleted just as a bystander of some unknown tumor suppressor genes of B cell tumorigenesis localized on chromosome 6q. Twenty-seven out of 30 patients analysed had diuse large cell type lymphoma, and the remaining three included diuse mixed, small cleaved and marginal zone types. All patients with LOH of the BACH2 gene belonged to the diuse large cell group. Three out of the ®ve patients survived more than 2.5 years, indicating that LOH of the BACH2 gene may not be a factor that presupposes a poor prognosis. Although the number of the cases included in the present study was small, the possibility of an association between LOH of BACH2 and development of B-cell malignancies is worth further investigation in a large series.
Materials and methods
Isolation of human BACH2 cDNA clones
Human endothelial cell and K562 erythroleukemic cell cDNA libraries constructed in the lgt11 vector were plated on 150 mm Petri dishes at a density of 5610 4 plaque-forming units (pfu) per plate. One610 6 pfu were screened with a mouse Bach2 cDNA fragment (Oyake et al., 1996) . Duplicated ®lters were made from each plate and processed for hybridization to the probe as described previously (Ito et al., 1993) . This was carried out in the presence of 66SSC and 0.25% skim milk at 558C overnight. Filters were washed in 26SSC/0.1% SDS at room temperature and 0.56SSC/ 0.1% SDS at 558C. Positive clones were puri®ed by two additional plaque hybridization screenings. Inserts of positive phage clones were then subcloned into the EcoRI site of the pBluescript KS(+) plasmid (Stratagene) and sequenced on both strands using a Sequenase version 2.0 DNA sequencing kit (Amersham) or an ABI PRISM Cycle sequencing kit (Applied Biosystems).
Cell culture
Hematopoietic cell lines were maintained in RPMI1640 (Nissui) medium supplemented with 10% fetal bovine serum (FBS), at 378C and in 5% CO 2 atmosphere. NALL-1, NALM-6, BALM-2, NAMALWA and RPMI 8226 cells were gifts of Dr K Ohtani, Fujisaki Cell Center of Hayashibara Bichemical Laboratories, Inc. (Okayama). KOPT-K1, THP-6 and NALM-17 cells were provided by Dr Y Hayashi, the University of Tokyo. MGS cells were donated by Dr S Yokoyama, Yamagata University, and KG-1, HL60, U937, THP1, RAMOS, Daudi, RPMI1788, KMS-12-PE, IM-9 and HS-Sultan were obtained from the Japanese Cancer Resources Bank (Tokyo).
Immunoblot analysis
Whole-cell extracts were prepared using triple-detergent lysis buer consisting of 50 mM Tris-HCl, 150 mM NaCl, 0.02% sodium azide, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate and 0.6 mM PMSF, and were separated on SDS-polyacrylamide gels. Proteins were transferred onto polyvinylidene di¯uoride membranes (Waters) and processed for reaction with the antiserum against Bach2 (F69-2; Oyake et al., 1996) . Secondary anti-rabbit IgG antibodies were conjugated with horseradish peroxidase, and detection of peroxidase activity was carried out with the enhanced chemiluminescence system (Amersham).
Northern hybridization
Poly(A)
+ RNAs were isolated from human hematopoietic cell lines with a Quickprep micro mRNA puri®cation kit (Pharmacia Biotec). Approximately 2 mg aliquots of Poly(A) + RNAs were separated on 1% agarose-formaldehyde gels and transferred to Hybond-N + membranes (Amersham) as described previously (Ito et al., 1993) . Northern blots containing multiple human tissue RNA samples were purchased from Clontech, each tissue sample containing 2 mg of poly(A) + RNA. Hybridization with a 32 P-labeled human BACH2 cDNA fragment containing the CNC domain and bZip domain, or rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA, and subsequent washings were carried out as described previously (Toki et al., 1997) .
Primary hematopoietic cell culture
Human umbilical cord blood (CB) was collected from healthy, full-term neonates according to institutional guidelines immediately after vaginal delivery. Mononuclear cells (MNCs) were separated by Ficoll density gradient centrifugation after depletion of phagocytes with silica (IBL) as described elsewhere (Imai et al., 1991) . CB CD34+ cells were isolated from MNCs by using Dynabeads M-450 conjugated with CD34 monoclonal Ab (mAb) and DETACHaBEAD CD34 (Dynal) as described previously (Sui et al., 1995) . CB CD34+107, CD34+10+ cells were puri®ed from CB CD34+ cells by cell sorting on FACS Vantage (Becton Dickinson). Puri®ed CB CD34+ cells were plated at a density of 1610 3 cells/ml onto the MS-5 feeders in a-MEM supplemented with 10% FCS, recombinant human (rh) stem cell factor (rhSCF) and granulocyte-colony-stimulating factor (rhG-CSF) as described before (Nishihira et al., 1998) . All cultures were conducted in a 378C, humidi®ed incubator containing 5% CO 2 in air, and the cultures were fed every week by removing half of medium and replacing it with fresh medium. Cytokines were also added at the time of feeding. After 2 ± 6 weeks, cells were harvested from the dishes by using 0.05% trypsin (Gibco) plus 0.02% ethylenediaminetetracetic acid (Wako), and the number of viable cells per well was determined.
Fluorescent antibodies and phenotype analysis
Cyto¯uorometric studies were performed using¯uorescent isothiocyanate (FITC)-, phycoerythrin (PE)-and PEcyanin5 isothiocyanate (PECy5)-conjugated mAbs. PE-CD19 (Leu-12) and FITC-CD34 (HPCA-2) mAbs were purchased from B&D. FITC and PE-CD10 (SS2/36) mAbs were purchased from DAKO. FITC-conjugated goat anity puri®ed F(ab')2 Ab to human mH chain was used to detect human Cm and Sm, and FITC-conjugated goat anity puri®ed F(ab')2 to rabbit Ig was used as a negative control. Both were purchased from Tago. Biotin-conjugated goat polyclonal Ab to mouse Ig (DAKO) and Tricolor (TC)-conjugated streptavidin (Caltag Lab.) were used to stain these puri®ed Abs. For all Abs, negative controls were provided by Ig of the same isotype but unrelated speci®city. The surface phenotype of culture cells was determined by two or three-color¯ow cytometry on a FACS (Cytoron Absolute). Culture cells were incubated for 30 min at room temperature with 0.5% human g-globulin (Sigma) or 0.5% normal mouse serum (DAKO) to block nonspeci®c binding. After washing, cells were then stained with¯uorescent-conjugated Abs.
RT ± PCR assays
One610
5 cells of fractions (CD34+10+ and CD34+107) in CB cells and fraction (CD10+19+cells) in generated B cells from CB CD34+ cells on MS-5 were sorted by FACS Vantage. The total RNA was isolated following procedures described by the manufacturer (Qiagen). Genomic DNA in total RNA was digested by DNAase I (Life Technologies) and DNAase I was inactivated by heat for 10 min. The synthesis of ®rst strand cDNA (reverse transcription (RT)) was performed for 60 min at 428C using oligo (dT)12 ± 18 and Superscript II reverse transcriptase (Life Technologies). The cDNa solution was ampli®ed using EX Taq polymerase (Takara) and each oligonucleotide as primer; humna G3PDH: sense, 5'-ACCACAGTCCATGCCATCAC-3', and antisense, 5'-TCCACCACCCTGTTGCTGTA-3', at 608C; human S14: sense, 5'-GGCAGACCGAGATGAATCCTCA-3', antisense, 5'-CAGGTCCAGGGGTCTTGGTCC-3' at 558C; human BACH2: sense, 5'-TCCTTGCCACAGAACAT-CAGGAAC-3' and antisense, 5'-TGGATGTCTCGG-CAAACTTCCTGG-3', at 558C. To insure that PCR products were not derived from DNA, primers were de®ned from discrete exons for each transcript. The ®rst cycle was run as follows: denaturation at 948C for 3 min, annealing at temperatures indicated above for 30 s, and synthesis at 728C for 30 s. The next 29 cycles were run similarly and the synthesis of last cycle was 5 min. The ampli®ed products were resolved by electrophoresis in 2% agarose gel. The products, obtained with each set of primers, were sequenced using the Ready Reaction Dye Determinator (Perkin-Elmer Corp., Norwalk) and an automated DNA sequencer (model 373; Applied Biosystems, Inc.).
BACH2 retrovirus and gene transduction into RAJI cells
A BamHI and SalI fragment containing the human BACH2 cDNA was inserted into the unique corresponding cloning sites of pDL + retrovirus vector (Nakao et al., 1995) . The amphotrophic packaging cell line PAMP51 that was kindly provided by Drs K Ikenaka and T Yoshimatsu (National Institute of Physiological Science, Okazaki, Japan) was transfected with pDL + -BACH2 plasmid by using Lipofect-AMINE Reagent (GIBCO ± BRL) as described previously (Yoshimatsu et al., 1998) . The stable amphotrophic producer cells were established after selection in the medium containing 1 mg/ml of G418 (GIBCO ± BRL). The virus supernatants were harvested from the producer cells cultured at 328C.
Gene transduction into RAJI cells was performed as follows. One ml of RAJI cells at a concentration of 10 5 ml in RPMI1640 containing 10% FCS and 1 ml of the virus supernatants were placed into the RetroNection TM Dish (TaKaRa), which is a precoated culture dish (35 mm) with a recombinant human ®bronectin fragment RetroNectin TM (TaKaRa). Stable transfectants were selected in the medium containing 1 mg ml of G418, and then single cell clones were established by the limiting dilution method.
Electrophoretic mobility shift assay (EMSA)
An oligonucleotide probe was from the IgH HS3 (5'-GCTGAGGGCAGCTGAGTCATCCTGAGCCT-3').
The double-stranded oligonucleotide was labeled with [g-32P]ATP and T4 Polynucleotide Kinase (TOYOBO). Incubation of B cell extracts with the DNA probe was carried out at 378C for 10 min under the conditions described previously (Muto et al., 1998) . Where indicated, antibodies were added to the binding reaction at dilution of 1/10 and chilled for 30 min on ice before addition of DNA. The reaction products were electrophoresed on 4% polyacrylamide gels. Nuclear extracts from RAJI cells were prepared from 10 7 cells as described previously (Andrews and Faller, 1991) .
Colony growth in methylcellulose culture
The clonogenic activity of each RAJI cell subclone was evaluated by methylcellulose culture. Five610 2 RAJI cells were placed in 1 ml of RPMI medium containing 0.88% methylcellulose and 10% FCS in triplicate, and incubated under fully humidi®ed conditions in 6-well culture dish (IWAKI) at 378C in 5% CO 2 atmosphere. Colonies were counted under an inverted microscope on days 7 and 11 after plating.
Fluorescence in situ hybridization (FISH) mapping
The human BACH2 cDNA clone was used to screen a commercial P1 phage human genomic library (Genomic Systems), and a human BACH2 genomic clone was isolated. Detailed analysis of the genomic structure will be reported elsewhere. FISH analysis was performed on metaphase cells obtained from normal human lymphocyte cultures as described earlier (Inazawa et al., 1993) .
Isolation of (CA)n repeat microsatellite marker in BACH2 genomic clone To identify the polymorphic marker (microsatellite) in the P1 phage genomic clone, a Southern blot analysis was performed using the (CA) 20 oligonucleotide as a probe, and selected fragments were subcloned into the Bluescript KS(+) plasmid (Stratagene). DNA sequences were determined on both strands by dideoxynucleotide methods using an ABI PRISM Cycle sequencing kit (Applied Biosystems). The microsatellite marker thus obtained was termed BACH2/CA-1, and had 25 repetititions of the CA sequence.
Tissue samples
Thirty matched samples of normal and tumor DNA were obtained from consenting patients with B-cell diuse NHL (diuse large cell type, 27 cases; diuse mixed cell type, 1 case; diuse small cleaved cell type, 1 case; marginal zone type, 1 case). B cell phenotype was evaluated by immunohistochemical analysis using anti-CD20 monoclonal antibody. We used biopsied lymph nodes involved by tumor and an extranodal lesion (one case from thyroid) as tumor samples. Mononuclear cells separated from peripheral blood or bone marrow, which were microscopically determined to have no contamination by malignant cells, were used as normal samples. DNA extraction was performed using the method described previously (Uchida et al., 1997) .
Loss of heterozygosity (LOH) analysis and patients
The primer sequences for the microsatellite BACH/CA-1 were as follows: Sense, 5'-CTGCAGGGAATAGGTAACTGT-3'; antisense, 5'-AAAGTGCAGGACCCCTCTGA-3'. Fifty ng aliquots of genomic DNA were subjected to PCR, performed in 25 ml containing 100 mM of each dNTP, 1 mM of each primer and 12.5 ml of Premix taq (TaKaRa). The reaction mixture was heated to 948C for 5 min followed by 30 cycles of 30 s at 948C, 30 s at 508C, 1 min at 728C, followed by a 5 min ®nal extension at 728C with a Gene Amp PCR System (Perkin-Elmer). The PCR products were electrophoretically separated on 10% denaturing polyacrylamide gels and then stained by Silver Stain Plus (BIO-RAD) according to the manufacturer's recommendations.
